ASCO 2012: Phase III CORRECT trial in mCRC
Dr. Mark Vincent, of London Health Sciences Centre, presents highlights from - Gastrointestinal (Colorectal) Cancer Oral Abstract Session: Efficacy and Safety Results of the International GERCOR DREAM phase III trial in mCRC (ASCO 2012).
Written by Simon Ashdown on June 25, 2012